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This study was carried out to clarify the influence of incomplete bile duct obstruction (IBDO) on the
occurrence and proliferation of cholangiocarcinoma and to evaluate the effect of release of IBDO at an
early stage, using 175 Syrian golden hamsters. These hamsters received 500mg/kg body weight of
diisopropanolnitrosamine (DIPN) once weekly for 10 weeks, and then were divided into 3 groups,
consisting of the simple laparotomy group (SL group), the IBDO group and 2 week IBDO group, in
which IBDO was released after 2 weeks. The occurrence rates of cholangiocarcinoma at 20 weeks were
42% in the SL group, 76% in the IBDO group and 30% in the 2 week IBDO group. The mean numbers
of tumors per hamster in the IBDO group were significantly greater than those in other groups (p <
0.05). Both occurrence rates and numbers of tumors in the 2 week IBDO group were similar to those in
the SL group. The proliferation of bile ductules and isolation of bacteria from bile in the IBDO group
had higher rates at 15, 20 weeks than those found in the other groups. These results suggest that IBDO
has an influence, as promoter, on the occurrence of cholangiocarcinoma induced by DIPN, and the
disappearance of its promoting effect is caused by release of the obstruction.
KEY WORDS: Cholangiocarcinoma, diisopropanolnitrosamine, incomplete bile duct obstruction, bile
ductules, bile infection
INTRODUCTION
The occurrence of cholangiocarcinoma in the liver has been observed during the
follow-up of patients with hepato-biliary diseases accompanying morphological
abnormality in the intra- or extrahepatic bile duct, and including intrahepatic stone
disease 1-3. Bile stasis and cholangitis caused by incomplete or complete bile duct
obstruction are recognized commonly in these diseases. There is an inferred
relationship between these clinical features and the occurrence of cholangiocarci-
noma. Yamamoto
4 reported that in rats with obstruction of the choledochus,
proliferation of bile ductules was an important factor in the occurrence of cholan-
giocarcinoma induced by diethylnitrosamine (DENA). Kinami et al. administered
diisopropanolnitrosamine (DIPN) to hamsters with incomplete bile duct obstruc-
tion (IBDO), and observed the promoting effect of IBDO on the occurrence of
cholangiocarcinoma. These investigations reveal that obstruction of the bile duct is
an important factor in the occurrence of cholangiocarcinoma, and simultaneously
suggest its clinical significance in the release of bile duct obstruction at an early
stage. This study was carried out to clarify experimentally these observations.
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MATERIALS AND METHODS
One hundred and seventy male 8-week-old Syrian golden hamsters were used.
These animals were kept under standardized conditions (room temperature, 23 +_
5C; humidity, 60 _+ 20%), and received MM-3 pellet diet (Funabashi Co.) and
water ad libitum. As a carcinogen, 500mg/kg body weight (10ml/kg) of DIPN
,l’okyo Chemical Co.) in saline was administered subcutaneously to all hamsters
once weekly for 10 weeks. At 10 weeks, these hamsters underwent procedures as
follows, and were divided into 3 groups. Forty hamsters underwent a simple
laparotomy (SL) as a sham operation after being anesthetized by intraabdominal
injection of 50 mg sodium pentobarbital/kg body weight, and were named the ’SL
group’. Using the same anesthetic, 65 hamsters underwent IBDO by means of
ligation of the choledochus adjacent to the pancreas, using 6-0 catgut. These were
named the ’IBDO group’. Forty-five hamsters underwent IBDO by means of loose
ligation of the choledochus in order to avoid complete obstruction, using 7-0 silk.
After 2 weeks, the knot was untied and the silk removed to release the obstruction.
These hamsteres were named the ’2 week IBDO group’. Some hamsters dropped
out due to various causes over the 20 week period, so that 36 of the ’SL group’, 54
of the ’IBDO group’ and 35 of the ’2 week IBDO group’ were evaluated. In
addition, 6 hamsters before and another six hamsters 10 weeks after the beginning
of DIPN administration were used to examine the serum bilirubin and alkaline
phosphatase, or bacteria in the bile.
The hamsters in each group were sacrificed 12, 15 and 20 weeks after the
beginning of DIPN administration, in order to perform the various examinations.
After collecting the bile, a mixture of barium sulfate and gelatin was infused into
the choledochus of 15 hamsters in each group, and the liver was removed and fixed
in 10% formalin. Then, cholangiography was carried out using softex photography
to investigate the condition of the bile duct. Thirty-six hamsters of the SL group, 54
of the IBDO group and 35 of the 2 week IBDO group wre used to examine the
histological changes in the liver. The liver fixed with formalin was sliced at 3 mm
intervals. Each slice was embedded in paraffin, and sectioned at 7. The sections
were stained with hematoxylin and eosin, and then examined under light micros-
copy. Histological changes in the intrahepatic bile duct, occurrence rates, number
per hamster and maximum diameter of cholangiocarcinoma were studied in
hamsters of each group.
The bilirubin and alkaline phosphatase levels in serum and the isolation rates of
bacteria from bile were determined. The biochemical determination was performed
in 18 hamsters of each group. The bacteriological examination was carried out in 25
hamsters of the SL group, 28 of the IBDO group and 27 of the 2 week IBDO group.
Blood taken from the inferior vena cava was centrifuged for 15 min at 3000 rpm,
and the serum was obtained. The determinations of bilirubin and alkaline phospha-
tase levels were performed using an autoanalyzer (736-type, Hitachi Co.). In the
SL and 2 week IBDO group, a cannula was inserted into the choledochus, and the
bile was collected by natural flow. In the IBDO group, the dilated choledochus was
punctured, and the bile was absorbed. To detect bacteria in the bile, an EG agar
plate (Eiken Chemical Co.) was used, and the culture was carried out at 37C for 48
hours. A GasPak(R) system (BBL) was used to incubate anaerobes. The identifica-
tion of bacteria was performed using gram stain and the vitek system (VITEK).INCOMPLETE BILE DUCT OBSTRUCTION 119
Statistical analysis was performed as follows. The values measured were pre-
sented as the mean +_ SD. Scheffe’s multiple comparison was adopted to compare
the values among the groups, and Dunn’s multiple comparison was used for
comparison of the number of tumors. Cox’s method was used for comparison of
percentage data.
RESULTS
1. The bile duct findings in cholangiograms
The cholangiograms at 12, 15 and 20 weeks in the IBDO group and at 12 weeks
in the 2 week IBDO group exhibited marked dilatation of intra- and extrahepatic
bile ducts and incomplete obstruction at the lower choledochus. The stricture,
obstruction or displacement of the intrahepatic bile duct caused by invasion of
tumors was observed in hamsters with occurrence of cholangiocarcinoma of the
IBDO group at 20 weeks. But these changes were obscure in hamsters with tumor
of the other groups. In the 2 week IBDO group, the cholangiograms at 15 and 20
weeks revealed the disappearance of bile duct dilatation and incomplete obstruc-
tion in the choledochus (Figure 1).
Figure Cholangiograms of hamsters in the IBDO group (a) and in the 2 week IBDO group (b) at 20
weeks. (a): showing marked dilatation and stenosis of the intra- and extrahepatic bile duct. (b): showing
disappearance of marked dilatation.
2. Pathological findings in the liver
Tumors in the liver, appearing as white nodules of 0.1-1.7 cm in size, were
observed in hamsters of all groups 15 and 20 weeks after beginning of DIPN
administration. These tumors revealed cholangiocarcinoma associated with minute
connective stroma in histological examination, in which carcinoma cells formed
acini and trabeculae of various sizes (Figure 2 a). Invasion of carcinoma cells into
the liver parenchyma was observed around the lesion.120 Y. KINAMI ETAL.
Histological changes in the intrahepatic bile duct were seen in hamsters of each
group. The proliferation of bile ductules, including cystic formation, goblet cell
metaplasia and papillary hyperplasia of the bile duct epithelium were the main
benign changes in the liver (Figure 2 b-d). The occurrence rates of proliferation of
bile ductules or cystic bile ductules at 15 and 20 weeks in the IBDO group were
higher than those in the other groups, but there was no significant difference (Table
1). The occurrence rates of goblet cell metaplasia or papillary hyperplasia in this
group were also higher than those in the other groups, but there was no significant
difference. In the 2 week IBDO group, the occurrrence rates of these histological
changes after release of obstruction were similar to those in the SL group.
Figure 2 Histological findings of the intrahepatic bile duct in hamsters with administration of DIPN. (a):
cholangiocarcinoma associated with minute connective stroma. (HE, X 50). (b): proliferation of bile
ductules. (c): proliferation of cystic bile ductules. (d): papillary hyperplasia. (HE, X 250).
3. Occurrence and proliferation of cholangiocarcinoma
The occurrence rates of cholangiocarcinoma at 15 and 20 weeks in the IBDO
group were 64% and 76% respectively, and were higher than those in the other
groups (Table 2). There was a significant difference in the occurrence rate at 15
weeks between the SL and IBDO groups (p < 0.05). The occurrence rates at
respective weeks in the 2 week IBDO group were similar to those in the SL group.121122 Y. KINAMI ETAL.
Table 2 Occurrence rates for cholangiocarcinoma and number of tumors per hamster in each group
Time after beginning ofDIPN administration
15 weeks 20 weeks
Occurrence Number of Occurrence Number of
Groups rates tumors/ rates tumors/
SL 17% (2/12) 1.0-t-0 42% (5/12)
IBDO 64% (14/22) 3.4 + 1.8 76% (16/21)
2 week IBDO 29% (4/14) 1.0+0 30% (3/10)
Number of hamsters.





The mean numbers of tumors per hamster at 15 and 20 weeks in the IBDO group
were significantly larger than those in the other groups (p < 0.05), whereas there
was no difference between the SL and 2 week IBDO groups. Regarding the tumor
size, tumors in hamsters with IBDO were slightly larger than those in hamsters
without it, but there was no significant difference (Table 3).
Table 3 Relationship between the size and number of tumors in each group
Time after beginning ofDIPN administration
15 weeks 20 weeks
Size of tumors (mm) Size of tumors (mm)
Groups -5 5-10 10- -5 5-10 10-
SL 100% (2) 0% 0% 67% (4) 33% (2) 0%
IBDO 70% (35) 22% (11) 8% (4) 41% (21) 22% (11) 37% (19)
2 week IBDO 75% (3) 25% (1) 0% 25% (1) 50% (2) 25%(1)
Number of tumors.
4. Changes in serum bilirubin and alkaline phosphatase
As shown in Table 4, the serum bilirubin levels in the SL group were constant
over a 20 week period, while those in the other groups were elevated after
incomplete obstruction of the choledochus. In the 2 week IBDO group, the levels
were reduced following release of obstruction. The serum alkaline phosphatase
levels in all groups were elevated after beginning of DIPN administration. The
levels in the SL group were constant 10 week later, but those in the IBDO group
were elevated still further. The levels in the 2 week IBDO group were reduced
following release of obstruction, and were similar to those in the SL group at 20
weeks.
5. Isolation rates of bacteria from bile
Bacteria were not detected in the bile of the SL group throughout the whole
course, but were detected in the bile of 2 groups receiving IBDO after 12 weeks
(Table 5). The isolation rates of bacteria from bile at 15 and 20 weeks in the IBDOINCOMPLETE BILE DUCT OBSTRUCTION 123
group were 82% and 70%, respectively and were higher than those in the 2 week
IBDO group. Except for unidentified bacteria, those of 13 varieties, including E.
coli, Bacteroides, Streptococcus and others, were isolated from bile of 2 groups
with IBDO.
Table 4.Changes of serum bilirubin and alkaline phosphatase (AL-P) levels in each group
After beginning ofDIPN administration
Groups Examinations n Before 10 weeks 12 weeks 15 weeks 20 weeks
SL 6 0.3 -+0.1 0.5 +_0.2 0.4-+0.2 0.4 +0.2 0.4-+0.2
IBDO Bilirubin levels
(C) 6 0.3+-0.1 0.5+-0.2/ 3.44-2.0 5.9+-2.50 5.1+_0.70
2 week IBDO 6 0.3 4- 0.1 0.5 +- 0.2 a 3.4 2.0b 0.5 + 0.2 0.5 +- 0.2
SL 6 146+-19 3104-38 3404-38 3144-22 298+_20
IBDO AL-P levels
(C) 6 1464-19 310+_ 38/ 384_+53 422 4- 72 482 +- 28
2 week IBDO 6 146 +_ 19 310 4- 38/x 384 +_ 53 376 +_ 91 316 +_ 42
mean 4- SD.
/x Incomplete obstruction. Release of obstruction, a-b p< 0.05. c-d,d-e p< 0.001.
Table 5 Isolation rates of bacteria from bile in each group
Isolation rates of bacteria
After beginning ofDIPN administration
Groups Before 10 weeks 12 weeks 15 weeks 20 weeks
SL 0% (0/6) 0% (0/6) 0% (0/5) 0% (0/12) 0% (0/8)
IBDO 0% (0/6) 0% (0/6)/x 29% (2/7) 82% (9/11) 70% (7/10)
2 week IBDO 0% (0/6) 0% (0/6)/x 29% (2/7) 30% (3/10) 30% (3/10)
Number of hamsters, zx Incomplete obstruction. Release of obstruction, a-b p< 0.05
DISCUSSION
Carcinogens for inducing cholangiocarcinoma in animals, 1’6’7’8 are already well
known. The DIPN used in this study is a substance discovered by Althoff et al. and
Pour et a/. 1’11, who examined the carcinogenic effect of di-n-propylnitrosamine and
its fl-oxidized compounds in the Syrian golden hamster. They observed the
occurrence of, not only pancreatic carcinoma, but also cholangiocarcinoma by
12 DIPN administration Kinami et al. studied the influence of IBDO on the
occurrence of cholangiocarcinoma induced by DIPN in a previous experiment using
hamsters, in which administration of the carcinogen was continued for 20 weeks
and was started simultaneously with IBDO. We reported the promoting effect of
IBDO on carcinogenesis. In this study the IBDO was performed after DIPN
administration for 10 weeks, and its influence on the occurrence of cholangiocarci-
noma was examined. Also, the effect of the release of obstruction at an early stage
on carcinogenesis was also evaluated.124 Y. KINAMI ET AL.
Ligation of the choledochus, using a silk or nylon thread, was generally
performed as a means of bile duct obstruction4. The single ligation method of the
choledochus using 6-0 catgut, making it possible to maintain the IBDO for a long
term, and a loose ligation method using 7-0 silk were used in this study. The latter
method performed in the 2 week IBDO group was beneficial because of the 2
weeks long maintenance of the IBDO and removal of the ligated silk.
Cholangiography proved that these methods were suitable for the purpose of this
study.
Pour et al. 12 observed the occurrence of hemangioendothelioma, angiosarcoma
and hepatoma, in addition to cholangioma and cholangiocarcinoma, in the liver of
hamsters administered 2, 2’-dihydroxy-di-n-propylnitrosamine dissolved in olive
oil. In a similar examination, Kajikawa et al. 14 reported a hamster in which not only
adenoma and cholangiocarcinoma, but also hemangioendothelioma was induced.
On the contrary, our results revealed no other neoplasm, except proliferation of
bile ductules and cholangiocarcinoma, in the liver of hamsters receiving DIPN
dissolved in saline. Yamamoto
4 mentioned that the lesion of bile ductules prolife-
ration acted as an important factor in the occurrence of cholangiocarcinoma in rats
treated with DENA. In our examination on hamsters with DIPN, it was assumed
that the changes in the epithelium of proliferated ductules were related to the
occurrence of cholangiocarcinoma, because an increased number of bile ductules
were seen around carinoma lesions. On the other hand, although the ductule
proliferation and changes in the bile duct epithelium were mainly based on DIPN
administration, our results indicated that the IBDO had a promoting effect on
these pathological changes; these changes in the IBDO group occurred at higher
rates than those in other groups. On the other hand, the occurrence rates of these
pathological changes in the 2 week IBDO group after release of obstruction were
similar to those in the SL group. Accordingly, this finding revealed that the effect of
release of the obstruction could be seen histologically.
The occurrence rates for cholangiocarcinoma at 15 and 20 weeks in the IBDO
group were higher than those in the SL and 2 week IBD.O group; besides, these
rates were higher than those seen in the literature1’3. The numbers of tumors per
hamster in the IBDO group were significantly large, compared with those in other
groups. Regarding the tumor size, tumors in the IBDO group were larger than
those in other groups, but there was no significant difference. These findings show
the promoting effect of IBDO on the occurrence and proliferation of cholangiocar-
cinoma and the absence of its effect in hamsters with IBDO for a short term.
As seen in the SL group, serum bilirubin levels did not change throughout the
whole course, but serum alkaline phosphatase levels were elevated after beginning
DIPN administration. It is presumed that the latter changes are caused by the
carcinogen, and are related to the histological changes in intrahepatic bile ducts.
Both levels were elevated after IBDO, but were reduced following its release. It is
inferred that bacterial infection occurs in the bile with stasis caused by bile duct
obstruction, and then, the conversion from primary to secondary bile acid is
promoted4’15. However, our examination performed previously did not reveal an
increase in secondary bile acid in the infected bile of hamsters with IBDO. Phinney
et al. reported a case of cholangiocarcinoma associated with Caroli’s disease, and
stated that, with the onset of cholangitis, bacterial enzymes might become available
to activate procarcinogens to the ultimate level of carcinogens. Regarding the
results of culture in this study, the IBDO group, with high occurrence rates of
tumor, exhibited high isolation rates of bacteria from bile. Besides, it wasINCOMPLETE BILE DUCT OBSTRUCTION 125
recognized that the release of bile duct obstruction at an early stage reduced
bacterial infection in the bile, as seen in the results of the 2 week IBDO group.
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INVITED COMMENTARY
Cholangiocarcinoma occurs throughout the biliary tree. As a result, the spectrum
of this malignancy includes a purely intrahepatic variety, perihilar tumors (the so-
called Klatskin tumor), distal bile duct tumors, and a diffuse intra- and extrahepatic
variety. Of these various types, only the distal bile duct tumors have a moderate
five-year survival of 30% to 50% following resection. Many of the intrahepatic
cholangiocarcinomas remain silent initially and present as large, often unresectable
and/or metastatic, liver tumors. The perihilar tumors that presumably present early
with jaundice and are said to be slow-growing also have a poor prognosis. In most
series 15% to 30% of patients with perihilar cholangiocarcinoma have peritoneal126 Y. KINAMI ETAL.
and/or liver metastases at the time of presentation. Moreover, even among the
resectable perihilar tumors, reported five-year survival rates are only 10% to 25%.
The prognosis for cholangiocarcinoma remains poor, in part, because it is a rare
entity. As a result, clinical studies to determine the pathogenesis and the results of
therapy have been limited. For these reasons, a good animal model for cholangio-
carcinoma is clearly needed. Thus, the present report by Kinami and his associates
is a welcome addition to the literature. The model they are using, diisopropanolni-
trosamine administration to the Syrian golden hamster, was first described 15 years
ago but was then infrequently applied until the present author’s 1988 report. This
model should be appropriate to determine the effects of radiotherapy, various
chemotherapeutic agents, and hormones on the growth of cholangiocarcinoma. To
study the effect of these potential therapies, however, survival data will have to be
determined.
Cholangiocarcinoma is known to occur with increased frequency in clinical
situations associated with prolonged biliary stasis. These entities include Caroli’s
disease, choledochal cysts, primary sclerosing cholangitis, and intrahepatic stone
disease. One pathogenetic theory has proposed that prolonged stasis increases
exposure of the biliary epithelium to carcinogens that are excreted in bile. The
present report by Kinami and his associates supports this theory. Measurements of
diisopropanolnitrosamine or its metabolites in bile would be an interesting addi-
tional study. Further clinical evidence that carcinogens may be excreted in bile, or
that bile may be a cocarcinogen, is the fact that periampullary tumors occur with
increa’sed frequency in the duodenum just distal to the ampulla.
The authors have clearly demonstrated that partial bile duct obstruction
enhances the growth of cholangiocarcinoma in their model. Whether this enhanced
tumor growth is the result of altered host immunity, increased concentration of the
chemical carcinogen, a cocarcinogen, or some other effect remains unclear. Bile
duct obstruction is known to alter hepatic reticuloendothelial, polymorphonuclear,
and lymphocyte function. Obstructive jaundice is also associated with increased
portal and systemic levels of endotoxin. This endotoxemia, in turn, may affect
hepatic, renal, cardiac, and pulmonary function. These profound effects on the
host may be sufficient to promote the growth of these animal, as well as human,
cholangiocarcinomas.
The most important observation made by Kinami et al. is that if biliary
obstruction is released after only two weeks, tumor growth is returned to baseline
levels. This finding needs to be further explored to determine whether a critical
period exists beyond which the effects of obstruction cannot be reversed. The
reversible effect of biliary obstruction on tumor growth in this model is also of
interest because of the lack of effect of relief of obstruction in clinical studies of
operative morbidity and mortality. These differing results may be explained,
however, by differences in the effects of 1) internal versus external biliary drainage,
2) partial versus complete obstruction, and 3) short versus long periods of
obstruction.
Another interesting question raised, but not answered, by-this study is whether
bacterial infection of the biliary system also plays a procarcinogenic effect. Each of
the clinical situations associated with prolonged bile stasis and an increased
incidence of cholangiocarcinoma are also associated with bactibilia and recurrent
episodes of cholangitis. In the present study the incidence of bactibilia closelyINCOMPLETE BILE DUCT OBSTRUCTION 127
paralleled the occurrence of cholangiocarcinoma. Interesting further studies in
which the incidence and growth of cholangiocarcinoma could be monitored would
explore the effect of 1) introducing bacteria into the biliary system at the time of
partial bile duct ligation or 2) treating the animals with antibiotics. Again, the
authors should be congratulated for reintroducing this animal model of cholangio-
carcinoma to the hepato-pancreato-biliary literature.
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